CA2489214C - Anticorps monoclonal anti-aurora-a, son procede d'obtention, et ses utilisations dans le diagnostic et le traitement des cancers - Google Patents

Anticorps monoclonal anti-aurora-a, son procede d'obtention, et ses utilisations dans le diagnostic et le traitement des cancers Download PDF

Info

Publication number
CA2489214C
CA2489214C CA2489214A CA2489214A CA2489214C CA 2489214 C CA2489214 C CA 2489214C CA 2489214 A CA2489214 A CA 2489214A CA 2489214 A CA2489214 A CA 2489214A CA 2489214 C CA2489214 C CA 2489214C
Authority
CA
Canada
Prior art keywords
aurora
protein
antibody
hybridomas
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA2489214A
Other languages
English (en)
French (fr)
Other versions
CA2489214A1 (fr
Inventor
Claude Prigent
Anne Martin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Etablissement Francais du Sang
Original Assignee
Centre National de la Recherche Scientifique CNRS
Etablissement Francais du Sang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Etablissement Francais du Sang filed Critical Centre National de la Recherche Scientifique CNRS
Publication of CA2489214A1 publication Critical patent/CA2489214A1/fr
Application granted granted Critical
Publication of CA2489214C publication Critical patent/CA2489214C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA2489214A 2002-06-12 2003-06-12 Anticorps monoclonal anti-aurora-a, son procede d'obtention, et ses utilisations dans le diagnostic et le traitement des cancers Expired - Lifetime CA2489214C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR02/07212 2002-06-12
FR0207212A FR2840905B1 (fr) 2002-06-12 2002-06-12 Anticorps monoclonal anti-aurora-a, son procede d'obtention, et ses utilisations dans le diagnostic et le traitement des cancers
PCT/FR2003/001772 WO2003106500A1 (fr) 2002-06-12 2003-06-12 Anticorps monoclonal anti-aurora-a, son procede d'obtention, et ses utilisations dans le diagnostic et le traitement des cancers

Publications (2)

Publication Number Publication Date
CA2489214A1 CA2489214A1 (fr) 2003-12-24
CA2489214C true CA2489214C (fr) 2013-08-06

Family

ID=29595167

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2489214A Expired - Lifetime CA2489214C (fr) 2002-06-12 2003-06-12 Anticorps monoclonal anti-aurora-a, son procede d'obtention, et ses utilisations dans le diagnostic et le traitement des cancers

Country Status (9)

Country Link
US (1) US7514231B2 (enExample)
EP (1) EP1511771B1 (enExample)
JP (1) JP4555681B2 (enExample)
AT (1) ATE420115T1 (enExample)
AU (1) AU2003255671A1 (enExample)
CA (1) CA2489214C (enExample)
DE (1) DE60325725D1 (enExample)
FR (1) FR2840905B1 (enExample)
WO (1) WO2003106500A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007514759A (ja) 2003-12-19 2007-06-07 タケダ サン ディエゴ インコーポレイテッド キナーゼ阻害剤
JP2008510734A (ja) 2004-08-18 2008-04-10 タケダ サン ディエゴ インコーポレイテッド キナーゼ阻害剤
DE602005023333D1 (de) 2004-10-15 2010-10-14 Takeda Pharmaceutical Kinaseinhibitoren
US8119655B2 (en) 2005-10-07 2012-02-21 Takeda Pharmaceutical Company Limited Kinase inhibitors
BRPI0719883A2 (pt) 2006-10-09 2015-05-05 Takeda Pharmaceutical Inibidores de quinase

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2239692C (en) * 1995-12-18 2008-12-16 Sugen, Inc. Diagnosis and treatment of aur-1 and/or aur-2 related disorders

Also Published As

Publication number Publication date
EP1511771B1 (fr) 2009-01-07
US20070117163A1 (en) 2007-05-24
ATE420115T1 (de) 2009-01-15
US7514231B2 (en) 2009-04-07
FR2840905A1 (fr) 2003-12-19
JP2006513135A (ja) 2006-04-20
AU2003255671A8 (en) 2003-12-31
EP1511771A1 (fr) 2005-03-09
AU2003255671A1 (en) 2003-12-31
FR2840905B1 (fr) 2006-07-07
CA2489214A1 (fr) 2003-12-24
WO2003106500A1 (fr) 2003-12-24
DE60325725D1 (de) 2009-02-26
JP4555681B2 (ja) 2010-10-06

Similar Documents

Publication Publication Date Title
JP3561268B2 (ja) レセプターチロシンキナーゼ標的タンパク質のｃＤＮＡクローニング方法及びｈＧＲＢタンパク質
Wong et al. The TGF-α precursor expressed on the cell surface binds to the EGF receptor on adjacent cells, leading to signal transduction
Egerton et al. VCP, the mammalian homolog of cdc48, is tyrosine phosphorylated in response to T cell antigen receptor activation.
Hashimoto et al. Phosphorylation of CrkII adaptor protein at tyrosine 221 by epidermal growth factor receptor
JPH09506250A (ja) Ｒｓｅと命名される蛋白チロシンキナーゼ
JPH09510861A (ja) 新規な蛋白質チロシンホスファターゼに対するヌクレオチド配列の一次構造および機能性発現
US20080274115A1 (en) Soluble ErbB3 Methods of Detection and Antibodies
AU2001263952B2 (en) Tumour suppressor and uses thereof
AU2001263952A1 (en) Tumour suppressor and uses thereof
CA2489214C (fr) Anticorps monoclonal anti-aurora-a, son procede d'obtention, et ses utilisations dans le diagnostic et le traitement des cancers
JPH09508795A (ja) Ｍａｐ キナーゼ ホスファターゼ及びそれらをコードする核酸の生産並びに使用
US5677421A (en) Target proteins for eukaryotic tyrosine kinases
US7871786B2 (en) GEF-H1b: biomarkers, complexes, assays and therapeutic uses thereof
US6770467B2 (en) Screening method for ligands with class II P13 kinase modulating activity
JP4719831B2 (ja) Ｔｐｌ−２／ｃｏｔキナーゼおよび使用方法
JPH10117788A (ja) ヒト・ｍｙｔ−１キナーゼクローン
EP0960337B1 (en) Cathepsin K and breast cancer
JP2007517502A (ja) 活性なｋｉｔチロシンキナーゼ受容体のモジュレーターを同定する方法
US5840536A (en) Growth factor receptor-binding insulin receptor
WO1997012971A1 (en) Ring finger protein
JP2004073142A (ja) Ｇａｎｐ結合性タンパク質
WO1997020573A1 (en) Growth factor receptor-binding protein 2 homolog
JPH09327292A (ja) プロテインキナーゼｎの改変タンパク質
JP2002355070A (ja) タウ−チューブリンキナーゼをコードするｄｎａ及びその利用
Occurring Cloning and Characterization of SCHIP-1

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20230612